Efficient human breast cancer xenograft regression after a single treatment with a novel liposomal formulation of epirubicin prepared using the EDTA ion gradient method.
Liposomes act as efficient drug carriers. Recently, epirubicin (EPI) formulation was developed using a novel EDTA ion gradient method for drug encapsulation. This formulation displayed very good stability and drug retention in vitro in a two-year long-term stability experiment. The cryo-TEM images s...
Main Authors: | Jerzy Gubernator, Dominik Lipka, Mariola Korycińska, Katarzyna Kempińska, Magdalena Milczarek, Joanna Wietrzyk, Rafał Hrynyk, Sabine Barnert, Regine Süss, Arkadiusz Kozubek |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24621591/?tool=EBI |
Similar Items
-
Vitamin C-driven epirubicin loading into liposomes
by: Lipka D, et al.
Published: (2013-09-01) -
The Effects and Mechanisms of a Novel Epirubicin in Liposomes on Cancer Cells
by: Hsin-Pin Lee, et al.
Published: (2014) -
The Cytotoxic Effect and Mechanism of Antisense Oligonucledtides and Epirubicin in Liposomes on Cancer
by: Yu Liu, et al.
Published: (2012) -
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies
by: Legut M, et al.
Published: (2014-01-01) -
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies [Corrigendum]
by: Legut M, et al.
Published: (2015-09-01)